Analystreport

Harpoon Therapeutics Inc (NASDAQ: HARP) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

Harpoon Therapeutics, Inc.  (HARP) 
Last harpoon therapeutics, inc. earnings: 3/12 04:05 pm Check Earnings Report